Randomized Outpatient Trial of Single- and Dual-Hormone Closed-Loop Systems That Adapt to Exercise Using Wearable Sensors

OBJECTIVE: Automated insulin delivery is the new standard for type 1 diabetes, but exercise-related hypoglycemia remains a challenge. Our aim was to determine whether a dual-hormone closed-loop system using wearable sensors to detect exercise and adjust dosing to reduce exercise-related hypoglycemia...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Diabetes Care
Autors principals: Castle, Jessica R., El Youssef, Joseph, Wilson, Leah M., Reddy, Ravi, Resalat, Navid, Branigan, Deborah, Ramsey, Katrina, Leitschuh, Joseph, Rajhbeharrysingh, Uma, Senf, Brian, Sugerman, Samuel M., Gabo, Virginia, Jacobs, Peter G.
Format: Artigo
Idioma:Inglês
Publicat: American Diabetes Association 2018
Matèries:
Emerging Therapies: Drugs and Regimens
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6014543/
https://ncbi.nlm.nih.gov/pubmed/29752345
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/dc18-0228
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars